Legal Representation
Attorney
Randolph E Digges, III
USPTO Deadlines
Next Deadline
2107 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251111)
Due Date
November 11, 2031
Grace Period Ends
May 11, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 11, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 11, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 23, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 23, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 17, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 26, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 26, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 26, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 26, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 26, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 25, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 25, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 25, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 15, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 17, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 17, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Mar 17, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Detailed Classifications
Class 001
Chemical, biochemical and biotechnological diagnostic preparations used in science, non-medical reagents, enzymes and chemicals, namely buffer solutions, used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning; chemical test kits for laboratory and research use for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning
First Use Anywhere:
Jun 12, 2024
First Use in Commerce:
Jun 12, 2024
Class 005
Diagnostic preparations for medical and veterinary purposes, namely diagnostics preparations for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes
First Use Anywhere:
Jun 12, 2024
First Use in Commerce:
Jun 12, 2024
Classification
International Classes
001
005